scispace - formally typeset
Y

Yuka Kanno

Researcher at National Institutes of Health

Publications -  98
Citations -  19864

Yuka Kanno is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Cellular differentiation & T cell. The author has an hindex of 56, co-authored 93 publications receiving 17367 citations. Previous affiliations of Yuka Kanno include University of Texas at Austin.

Papers
More filters
Journal ArticleDOI

Interleukin-2 Signaling via STAT5 Constrains T Helper 17 Cell Generation

TL;DR: It is demonstrated that in addition to the promotion of activation-induced cell death of lymphocytes and the generation of Treg cells, inhibition of Th17 polarization appears to be an important function of IL-2.
Journal ArticleDOI

Global Mapping of H3K4me3 and H3K27me3 Reveals Specificity and Plasticity in Lineage Fate Determination of Differentiating CD4+ T Cells

TL;DR: Although modifications of signature-cytokine genes (Ifng, Il4, and Il17) partially conform to the expectation of lineage commitment, genes encoding transcription factors like Tbx21 exhibit a broad spectrum of epigenetic states, consistent with the demonstrated T-bet and interferon-gamma induction in nTreg cells.
Journal ArticleDOI

Impaired T H 17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome

TL;DR: Ex vivo T cells from subjects with HIES failed to produce IL-17, but not IL-2, tumour-necrosis factor or interferon-γ, on mitogenic stimulation with staphylococcal enterotoxin B or on antigenic stimulation with Candida albicans or streptokinase, which is consistent with a crucial role for STAT3 signalling in the generation of TH17 cells.
Journal ArticleDOI

JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.

TL;DR: The biology of JAKs is discussed from a translational perspective, focusing on recent insights from clinical trials, the development of novel agents and the use of jakinibs in a spectrum of immune and inflammatory diseases.